Explore Next Generation Solutions for Cell Therapies
In this virtual lab, explore solutions for cell engineering, immunophenotyping, and high-throughput screening of optimal engineered immune cells. The success of these cell therapies depends on selective engineering of immune cells followed by extensive ex-vivo characterization to identify the optimal candidate. Agilent offers a growing number of solutions to assess engineered immune cell activation, potency, exhaustion, and metabolic phenotypes to determine cell fate, fitness and function.